英文名称:ε-N-Deoxyfructosyllysine 纯度:98% CAS编号:21291-40-7 产地:加拿大 别名:1-Deoxy-1-(ε-N-L-lysino)-D-fructose; Fructoselysine; Fructosyllysine; Nε-(1-Deoxy-D-fructos-1-yl)-L-lysine; ε-Fructoselysine; D-1-[(L-5-Amino-5-carboxypentyl)amino]-1-deoxyfructose; (S)-1-[(...
英文别名N-(1-Deoxy-D-fructosyl)-L-proline | 1-Deoxy-1-L-prolino-D-fructose | (2S)-1-[(3S,4R,5R)-3,4,5,6-tetrahydroxy-2-oxohexyl]pyrrolidine-2-carboxylic acid | DTXSID101306343 | BM3B50NJ2O | L-Proline, 1-(1-deoxy-D-fructos-1-yl)- | Q27274748 | SCHEMBL10602508 | J ...
英文别名: N-(1-deoxyfructosyl)amphotericin B中文名: 中文别名: CBNumber: CB21351316 分子式: C53H83NO22 分子量: 1086.21962 MOL File: 119829-29-7.mol 化学性质 安全信息 用途 供应商 0 N-(1-deoxyfructosyl)amphotericin B化学性质 安全信息
别名1-脱氧-1-(ε-N-L-赖氨酸)-D-果糖二盐酸盐 规格或纯度95% 英文名称epsilon-N-Deoxyfructosyllysine dihydrochloride 生化机理糖氨基酸具有潜在的抗氧化剂和抗炎特性。 储存温度2-8°C储存,避光,充氩 运输条件冰袋运输 备注如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制...
Process for preparing N(alpha)-(1-deoxy-D-fructosyl)- N(epsilon)-(2-(18F)fluoropropanoyl)-Lys0-Tyr3-octreotate by a nucleophilic substitution (Br- for [18F]) in the precursor 9-anthrylmethyl-2-bromopropanoate consists in that the 9-anthrylmethyl-2-bromopropanoate precursor is first ...
苯酸ACS, 99.5%epsilon-N-Deoxyfructosyllysine dihydrochloride, Sugar-amino acid 苯酸分析标准品2,4-Diacetylphloroglucinol, P. Fluorescens strain metabolite 苯酸≥99.5%, FCC, Kosher, FGDibenz[a,h]acridine, heterocyclic aromatic compound 苯酸Standard for quantitative NMRDibenz[a,h]acridine, heterocyclic...
Process for preparing N(alpha)-(1-deoxy-D-fructosyl)- N(epsilon)-(2-(18F)fluoropropanoyl)-Lys0-Tyr3-octreotate by a nucleophilic substitution (Br- for [18F]) in the precursor 9-anthrylmethyl-2-bromopropanoate consists in that the 9-anthrylmethyl-2-bromopropanoate precursor is first ...
Process for preparing N(alpha)-(1-deoxy-D-fructosyl)- N(epsilon)-(2-(18F)fluoropropanoyl)-Lys0-Tyr3-octreotate by a nucleophilic substitution (Br- for [18F]) in the precursor 9-anthrylmethyl-2-bromopropanoate consists in that the 9-anthrylmethyl-2-bromopropanoate precursor is first ...
In the present invention, there is described a process for preparing Ne{alpha}-(1-deoxy-D-fructosyl)-Ne{epsilon}-(2-(e18F)fluoropropanoyl)-Lyse0-Tyre3-oktreotate by nucleophilic substitution of Br- for [18F]- in the precursor - 9-anthrylmethyl-2-bromopropanoate. Said - 9-anthrylmethyl...
N #ALPHA# -(#ALPHA#-GLUCOSYL(1-4)-DEOXYFRUCTOSYL)-OCTREOTIDE AND PHARMACEUTICAL COMPOSITIONSThe present invention provides a sugar derivative of a biologically active peptide, which derivative has a prolonged duration of action when compared to the non-sugar modified peptide, and contains at least ...